{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:38:24Z","timestamp":1768703904567,"version":"3.49.0"},"reference-count":206,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.neuro.2008.04.016","type":"journal-article","created":{"date-parts":[[2008,5,5]],"date-time":"2008-05-05T05:25:30Z","timestamp":1209965130000},"page":"871-882","source":"Crossref","is-referenced-by-count":48,"title":["Type-2 alkenes mediate synaptotoxicity in neurodegenerative diseases"],"prefix":"10.1016","volume":"29","author":[{"given":"Richard M.","family":"LoPachin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence","family":"Gavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2008.04.016_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/009841000157005","article-title":"Neurotoxicity of ethyl methacrylate in rats","volume":"59","author":"Abou-Donia","year":"2000","journal-title":"J Toxicol Environ Health A"},{"key":"10.1016\/j.neuro.2008.04.016_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00041433-200206000-00009","article-title":"Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease","volume":"13","author":"Arlt","year":"2002","journal-title":"Curr Opin Lipid"},{"key":"10.1016\/j.neuro.2008.04.016_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.taap.2004.05.008","article-title":"Proteomic analysis of acrylamide\u2013protein adduct formation in rat brain synaptosomes","volume":"201","author":"Barber","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neuro.2008.04.016_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/toxsci\/kfm210","article-title":"Proteomic analysis of rat striatal synaptosomes during acrylamide intoxication at a low dose rate","volume":"100","author":"Barber","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat Rev"},{"key":"10.1016\/j.neuro.2008.04.016_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/10408448509037461","article-title":"A critical review of the literature on acrolein toxicity","volume":"14","author":"Beauchamp","year":"1985","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.neuro.2008.04.016_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1021\/tx960113p","article-title":"Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers","volume":"10","author":"Bergmark","year":"1997","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.neuro.2008.04.016_bib8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","article-title":"Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease","volume":"73","author":"Berman","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib10","first-page":"209","article-title":"Deterioration threshold of synaptic morphology in aging and senile dementia of Alzheimer's type","volume":"18","author":"Bertoni-Freddari","year":"1996","journal-title":"Anal Quant Cytol Histol"},{"key":"10.1016\/j.neuro.2008.04.016_bib11","article-title":"Esters. 3. Esters of alkenyl carboxylic acids and monoalcohols","volume":"vol. 11","author":"Bisesi","year":"1994"},{"key":"10.1016\/j.neuro.2008.04.016_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1021\/tx015552p","article-title":"Inhibition of cell proliferation and AP-1 activity by acrolein in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications","volume":"15","author":"Biswal","year":"2002","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.neuro.2008.04.016_bib13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/carcin\/bgg061","article-title":"Modulation of benzo[a]pyrene-induced p53 DNA activity by acrolein","volume":"24","author":"Biswal","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neuro.2008.04.016_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","article-title":"ALS: a disease of motor neurons and their nonneuronal neighbors","volume":"52","author":"Boillee","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2008.04.016_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.brainres.2005.02.086","article-title":"Proteomic identification of proteins oxidized by A\u03b2(1\u201342) in synaptosomes: implications for Alzheimer's disease","volume":"1044","author":"Boyd-Kimball","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2008.04.016_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1289\/ehp.8095","article-title":"Pesticides and Parkinson's disease- is there a link?","volume":"114","author":"Brown","year":"2006","journal-title":"Environ Health Persp"},{"key":"10.1016\/j.neuro.2008.04.016_bib17","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1289\/ehp.7567","article-title":"neurodegenerative diseases: an overview of environmental risk factors","volume":"113","author":"Brown","year":"2005","journal-title":"Environ Health Persp"},{"key":"10.1016\/j.neuro.2008.04.016_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuron.2004.09.006","article-title":"Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate","volume":"44","author":"Buckner","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2008.04.016_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0161-813X(03)00090-1","article-title":"Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases","volume":"25","author":"Burke","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2008.04.016_bib20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4914(01)02173-6","article-title":"Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid \u03b2-peptide","volume":"7","author":"Butterfield","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.neuro.2008.04.016_bib21","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0197-4580(01)00340-2","article-title":"Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death","volume":"23","author":"Butterfield","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2008.04.016_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0197-4580(92)90041-U","article-title":"Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions","volume":"13","author":"Cabalka","year":"1992","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2008.04.016_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1471-4159.1999.0720751.x","article-title":"Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease","volume":"72","author":"Calingasan","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainres.2004.01.036","article-title":"Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease","volume":"1004","author":"Castegna","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2008.04.016_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(01)02514-9","article-title":"Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans","volume":"319","author":"Castellani","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2008.04.016_bib26","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1523\/JNEUROSCI.0319-07.2007","article-title":"Reduced vesicular storage of dopamine causes progressive nitrostriatal neurodegeneration","volume":"27","author":"Caudle","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1021\/jp003786w","article-title":"Chemical reactivity and selectivity: local HSAB principal versus frontier orbital theory","volume":"105","author":"Chattaraj","year":"2001","journal-title":"J Phys Chem A"},{"key":"10.1016\/j.neuro.2008.04.016_bib28","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1523\/JNEUROSCI.2980-05.2005","article-title":"Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease","volume":"25","author":"Chin","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib29","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1523\/JNEUROSCI.3758-06.2007","article-title":"Reeling depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease","volume":"27","author":"Chin","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib30","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1523\/JNEUROSCI.1843-07.2007","article-title":"Amyloid \u03b2 protein modulates glutamate-mediated neurotransmission in the rat basal forebrain: involvement of presynaptic neuronal nicotinic acetylcholine and metabotropic glutamate receptors","volume":"27","author":"Chin","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neurobiolaging.2003.09.001","article-title":"Synaptic slaughter in Alzheimer's disease","volume":"24","author":"Coleman","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2008.04.016_bib32","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1212\/01.WNL.0000140626.48118.0A","article-title":"A focus on the synapse for neuroprotection in Alzheimer disease and other dementias","volume":"63","author":"Coleman","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2008.04.016_bib33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.jnen.0000179050.54522.5a","volume":"64","author":"Dalfo","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0022-510X(87)90057-8","article-title":"A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease","volume":"78","author":"Davies","year":"1987","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib35","article-title":"Alzheimer's disease-type neuronal tau hyperphophorylation induced by A\u03b2 oligomers","author":"DeFelice","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2008.04.016_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.410270502","article-title":"Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity","volume":"27","author":"DeKosky","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2004.01.008","article-title":"Alzheimer pathology disorganizes cortico-cortical circuitry: direct evidence from a transgenic animal model","volume":"16","author":"Delatour","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2008.04.016_bib38","series-title":"Drug treatment issues in Parkinson's disease","article-title":"Early detection of Parkinson's disease","author":"DiPaola","year":"2000"},{"key":"10.1016\/j.neuro.2008.04.016_bib39","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1523\/JNEUROSCI.23-17-06740.2003","article-title":"\u03b2-Amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex","volume":"23","author":"Dougherty","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib40","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/tx025590o","article-title":"Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxynonenal and 4-oxo-2-nonenal","volume":"15","author":"Doorn","year":"2002","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.neuro.2008.04.016_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0009-2797(02)00178-3","article-title":"Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal","volume":"143\/144","author":"Doorn","year":"2003","journal-title":"Chem Bio Interact"},{"key":"10.1016\/j.neuro.2008.04.016_bib42","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2169\/internalmedicine.34.824","article-title":"Amyotrophic lateral sclerosis","volume":"34","author":"Eisen","year":"1995","journal-title":"Int Med"},{"key":"10.1016\/j.neuro.2008.04.016_bib43","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","article-title":"NO as a signaling molecule in the nervous system","volume":"135","author":"Esplungues","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuro.2008.04.016_bib44","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1046\/j.1471-4159.1997.69052064.x","article-title":"Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis","volume":"69","author":"Ferrante","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib46","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1523\/JNEUROSCI.21-13-04691.2001","article-title":"Age-related impairment of synaptic transmission but normal long-term potentiation in transgenic mice that overexpress the human APP695SWE mutant form of amyloid precursor protein","volume":"21","author":"Fitzjohn","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbr.2004.05.024","article-title":"An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate","volume":"156","author":"Fleming","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuro.2008.04.016_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neuro.2006.07.018","article-title":"Inhibition of the oxidative metabolism of 3,4-dihydroxyphenylacetaldehyde, a reactive intermediate of dopamine metabolism, by 4-hydroxy-2-nonenal","volume":"28","author":"Florang","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2008.04.016_bib49","doi-asserted-by":"crossref","first-page":"C246","DOI":"10.1152\/ajpcell.00516.2003","article-title":"Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers","volume":"287","author":"Forman","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.neuro.2008.04.016_bib50","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1523\/JNEUROSCI.20-07-02534.2000","article-title":"Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases","volume":"20","author":"Frey","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib51","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1021\/jf030204+","article-title":"Chemistry, biochemistry and safety of acrylamide. A review","volume":"51","author":"Friedman","year":"2003","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.neuro.2008.04.016_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/(SICI)1099-1263(199801\/02)18:1<25::AID-JAT466>3.0.CO;2-V","article-title":"Relative neurotoxicological properties of five unsaturated nitriles in rats","volume":"18","author":"Gagnaire","year":"1999","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.neuro.2008.04.016_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410410106","article-title":"Neuronal loss correlates but exceeds neurofibrillary tangles in Alzheimer's disease","volume":"41","author":"Gomez-Isla","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib54","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.1834302100","article-title":"Alzheimer's disease-affected brain: presence of oligomeric A\u03b2 ligands (ADDLs) suggest a molecular basis for reversible memory loss","volume":"100","author":"Gong","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib55","first-page":"1717","article-title":"Pathological effects of acrolein in cultured human bronchial epithelial cells","volume":"48","author":"Grafstr\u00f6m","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.neuro.2008.04.016_bib56","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.1073\/pnas.0600729103","article-title":"Identification of S-nitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells","volume":"103","author":"Greco","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib57","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0002-9440(10)63436-0","article-title":"Synaptic changes in Alzheimer's disease- increased amyloid-\u03b2 and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence","volume":"165","author":"Gylys","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuro.2008.04.016_bib58","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: where are we now?","volume":"97","author":"Halliwell","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1212\/WNL.39.3.355","article-title":"Synaptic loss in Alzheimer's disease and other dimentias","volume":"39","author":"Hamos","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2008.04.016_bib60","first-page":"6213","article-title":"Treatment with an amyloid-\u03b2 ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's disease","volume":"25","author":"Hartman","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2008.04.016_bib61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.expneurol.2006.05.017","article-title":"Wlds mice are protected against the Parkinsonian mimetic MPTP","volume":"202","author":"Hasbani","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib62","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/0006-2952(70)90009-2","article-title":"Biochemical studies of acrylamide, a neurotoxic agent","volume":"19","author":"Hashimoto","year":"1970","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2008.04.016_bib63","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1073\/pnas.93.5.1956","article-title":"Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections","volume":"93","author":"Hastings","year":"1996","journal-title":"Proc Nat Acad Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib64","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrm1569","article-title":"Protein S-nitrosylation: purview and parameters","volume":"6","author":"Hess","year":"2005","journal-title":"Nat Rev"},{"key":"10.1016\/j.neuro.2008.04.016_bib65","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.pa.32.040192.002351","article-title":"Role of covalent and noncovalent interactions in cell toxicity: effects on proteins","volume":"32","author":"Hinson","year":"1992","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.neuro.2008.04.016_bib66","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.neurobiolaging.2003.04.005","article-title":"Pathology of presynaptic proteins in Alzheimer's disease: more than simple loss of terminals","volume":"24","author":"Honer","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2008.04.016_bib67","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, A\u03b2 elevation and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neuro.2008.04.016_bib68","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/bi971958i","article-title":"Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal","volume":"37","author":"Humphries","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuro.2008.04.016_bib69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s004010100449","article-title":"Differential expression between synaptic vesicle proteins and presynaptic plasma membrane proteins in the anterior horn of amyotrophic lateral sclerosis","volume":"103","author":"Ikemoto","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuro.2008.04.016_bib70","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00005072-199509000-00009","article-title":"Quantitative study of synaptophysin immunoreactivity of cerebral cortex and spinal cord in motor neuron disease","volume":"54","author":"Ince","year":"1995","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-510X(01)00481-6","article-title":"A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies","volume":"185","author":"Iseki","year":"2001","journal-title":"J Neurol Sci"},{"issue":"Suppl. 3","key":"10.1016\/j.neuro.2008.04.016_bib72","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib73","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/0006-2952(77)90267-2","article-title":"Effects of acrylamide intoxication on pyridine nucleotide concentrations and functions in rat cerebral cortex","volume":"26","author":"Johnson","year":"1977","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuro.2008.04.016_bib74","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1471-4159.1988.tb03016.x","article-title":"Altered cerebral protein turnover in rats following prolonged in vivo treatment with nicotine","volume":"50","author":"Katyare","year":"1988","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib75","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00401-006-0044-1","article-title":"Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain","volume":"111","author":"Kawaguchi-Niida","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuro.2008.04.016_bib76","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/toxsci\/57.1.6","article-title":"The molecular effects of acrolein","volume":"57","author":"Kehrer","year":"2000","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib77","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1471-4159.1997.69010273.x","article-title":"Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid \u03b2-peptide: role of the lipid peroxidation product 4-hydroxynonenal","volume":"69","author":"Keller","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib78","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0306-4522(97)00065-1","article-title":"4-Hydroxynonenal, an aldehyde product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes","volume":"80","author":"Keller","year":"1997","journal-title":"Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib79","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1515\/REVNEURO.1998.9.2.105","article-title":"Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction and death in the nervous system","volume":"9","author":"Keller","year":"1998","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib80","doi-asserted-by":"crossref","first-page":"28079","DOI":"10.1074\/jbc.M605081200","article-title":"\u03b2-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-d-Aspartate receptors in hippocampal neurons","volume":"281","author":"Kelly","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2008.04.016_bib81","doi-asserted-by":"crossref","first-page":"31746","DOI":"10.1074\/jbc.M503259200","article-title":"\u03b2-Amyloid-induced dynamin. 1. Depletion in hippocampal neurons","volume":"280","author":"Kelly","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2008.04.016_bib82","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/brain\/87.2.307","article-title":"Alzheimer's disease: an electron microscopical study","volume":"87","author":"Kidd","year":"1964","journal-title":"Brain"},{"key":"10.1016\/j.neuro.2008.04.016_bib83","article-title":"Production of the top 50 chemicals increased substantially in 1994","volume":"10\/22","author":"Kirschner","year":"1996","journal-title":"Chem Eng News"},{"key":"10.1016\/j.neuro.2008.04.016_bib84","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2006.03935.x","article-title":"Dow-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease","volume":"98","author":"Kirvell","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib85","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0361-9230(00)00282-3","article-title":"Role of nitric oxide in the regulation of monoaminergic neurotransmission","volume":"52","author":"Kiss","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuro.2008.04.016_bib86","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jalz.2005.11.003","article-title":"Synaptic targeting by A\u03b2 oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease","volume":"2","author":"Klein","year":"2006","journal-title":"Alzheimer's Dem"},{"key":"10.1016\/j.neuro.2008.04.016_bib87","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-2236(00)01749-5","article-title":"Targeting small A\u03b2 oligomers: the solution to an Alzheimer's disease conundrum?","volume":"24","author":"Klein","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib88","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1523\/JNEUROSCI.17-13-05089.1997","article-title":"Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis","volume":"17","author":"Kruman","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib89","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0003-9861(86)90547-3","article-title":"The role of mitochondrial glutathione and cellular protein sulfhydryls in formaldehyde toxicity in glutathione-depleted rat hepatocytes","volume":"247","author":"Ku","year":"1986","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.neuro.2008.04.016_bib90","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"A\u03b2 oligomers-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib91","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1523\/JNEUROSCI.3432-04.2004","article-title":"Synaptic targeting by Alzheimer's-related amyloid \u03b2 oligomers","volume":"24","author":"Lacor","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib92","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1289\/ehp.7571","article-title":"Early environmental origins of neurodegenerative disease in later life","volume":"113","author":"Landrigan","year":"2005","journal-title":"Environ Health Persp"},{"key":"10.1016\/j.neuro.2008.04.016_bib93","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1471-4159.2001.00451.x","article-title":"The glial glutamate transporter, GLT-1, is oxidatively, modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of A\u03b21-42","volume":"78","author":"Lauderback","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib94","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1471-4159.2001.00417.x","article-title":"Effect of overexpression of wild-type and mutant Cu\/Zn-superoxide dismutases on oxidative stress and cell death induced by hydrogen peroxide, 4-hydroxynonenal or serum deprivation: potentiation of injury by ALS-related mutant superoxide dismutases and protection by Bcl-2","volume":"78","author":"Lee","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib95","doi-asserted-by":"crossref","first-page":"13527","DOI":"10.1073\/pnas.212269799","article-title":"S-Nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase","volume":"99","author":"Leiper","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib96","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2008.04.016_bib97","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0197-4580(92)90115-E","article-title":"Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses","volume":"13","author":"Lippa","year":"1992","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2008.04.016_bib98","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0161-813X(01)00074-2","article-title":"Nerve terminals as the primary site of acrylamide action: a hypothesis","volume":"23","author":"LoPachin","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2008.04.016_bib99","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0041-008X(02)00072-8","article-title":"Acrylamide axonopathy revisited","volume":"188","author":"LoPachin","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neuro.2008.04.016_bib100","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuro.2004.01.004","article-title":"The changing view of acrylamide neurotoxicity","volume":"25","author":"LoPachin","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2008.04.016_bib101","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0161-813X(03)00149-9","article-title":"In vivo and in vitro effects of acrylamide on synaptosomal neurotransmitter uptake and release","volume":"25","author":"LoPachin","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuro.2008.04.016_bib102","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/toxsci\/kfi197","article-title":"Protein adduct formation as a molecular mechanism in neurotoxicity","volume":"86","author":"LoPachin","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib103","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/toxsci\/kfj005","article-title":"Acrylamide inhibits dopamine uptake in rat striatal synaptic vesicles","volume":"89","author":"LoPachin","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib104","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/toxsci\/kfl066","article-title":"Synaptic cysteine sulfhydryl groups as targets of electrophilic neurotoxicants","volume":"94","author":"LoPachin","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/toxsci\/kfl127","article-title":"Structure-toxicity analysis of Type-2 alkenes: in vitro neurotoxicity","volume":"95","author":"LoPachin","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib106","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/toxsci\/kfm127","article-title":"Neurotoxic mechanisms of electrophilic type-2 alkenes: soft\u2013soft interactions described by quantum mechanical parameters","volume":"98","author":"LoPachin","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib107","unstructured":"LoPachin RM, Geohagen BC, Gavin T. Synaptosomal toxicity and nucleophilic targets of 4-hydroxy-2-nonenal. Toxicol Sci, Submitted for publication."},{"key":"10.1016\/j.neuro.2008.04.016_bib108","doi-asserted-by":"crossref","unstructured":"LoPachin RM, Barber DS, Gavin T. Molecular mechanisms of the conjugated \u03b1,\u03b2-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases. Toxicol Sci 2008; doi:10.1093\/toxsci\/kfm301.","DOI":"10.1093\/toxsci\/kfm301"},{"key":"10.1016\/j.neuro.2008.04.016_bib109","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0197-4580(97)00108-5","article-title":"Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease","volume":"18","author":"Lovell","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2008.04.016_bib110","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0891-5849(00)00346-4","article-title":"Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures","volume":"29","author":"Lovell","year":"2000","journal-title":"Free Rad Biol Med"},{"key":"10.1016\/j.neuro.2008.04.016_bib111","first-page":"187","article-title":"Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures","volume":"22","author":"Lovell","year":"2001","journal-title":"Neurobiol"},{"key":"10.1016\/j.neuro.2008.04.016_bib112","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid \u03b2 peptide concentration as a predictor of synaptic change in Alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuro.2008.04.016_bib113","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuint.2004.09.001","article-title":"Acrolein induces oxidative stress in brain mitochondria","volume":"46","author":"Luo","year":"2005","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuro.2008.04.016_bib114","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neurobiolaging.2003.04.007","article-title":"Clogging of axon by tau, inhibition of axonal traffic and starvation of synapses","volume":"24","author":"Mandelkow","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2008.04.016_bib115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1471-4159.1997.68010255.x","article-title":"A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid \u03b2-peptide","volume":"68","author":"Mark","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib116","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.56.12.1449","article-title":"The role of oxidative stress in Alzheimer's disease","volume":"56","author":"Markesbery","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib117","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.56.1.127","article-title":"Altered expression of synaptic proteins occurs during early progression of Alzheimer's disease","volume":"56","author":"Masliah","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2008.04.016_bib118","first-page":"235","article-title":"Cortical and subcortical patterns of synatophysin-like immunoreactivity in Alzheimer's disease","volume":"138","author":"Masliah","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neuro.2008.04.016_bib119","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0304-3940(89)90582-X","article-title":"Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer's disease","volume":"103","author":"Masliah","year":"1989","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2008.04.016_bib120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","article-title":"Pathways towards and away from Alzheimer's disease","volume":"430","author":"Mattson","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2008.04.016_bib121","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0022-510X(94)90032-9","article-title":"Synaptic pathology of spinal anterior horn cells in amyotrophic lateral sclerosis: an immunohistochemical study","volume":"125","author":"Matsumoto","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib122","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1385\/MN:28:3:209","article-title":"Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease","volume":"28","author":"Meissner","year":"2003","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neuro.2008.04.016_bib123","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.neuroscience.2007.04.003","article-title":"Acrolein induces selective protein carbonylation in synaptosomes","volume":"147","author":"Mello","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2008.04.016_bib124","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0041-008X(92)90273-U","article-title":"Quinone chemistry and toxicity","volume":"112","author":"Monks","year":"1992","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neuro.2008.04.016_bib125","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00005072-199708000-00004","article-title":"4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease","volume":"56","author":"Montine","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib126","first-page":"437","article-title":"Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4","volume":"150","author":"Montine","year":"1997","journal-title":"Am Pathol"},{"key":"10.1016\/j.neuro.2008.04.016_bib127","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00005072-199805000-00005","article-title":"Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype","volume":"57","author":"Montine","year":"1998","journal-title":"J Neuropath Exp Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib128","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0891-5849(02)00807-9","article-title":"Lipid peroxidation in aging brain and Alzheimer's disease","volume":"33","author":"Montine","year":"2002","journal-title":"Free Rad Biol Med"},{"key":"10.1016\/j.neuro.2008.04.016_bib129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0197-0186(98)00062-X","article-title":"Effects of 4-hydroxynonenal, a lipid peroxidation product, on dopamine transport and Na+\/K+ ATPase in rat striatal synaptosomes","volume":"33","author":"Morel","year":"1999","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuro.2008.04.016_bib130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/toxsci\/58.1.182","article-title":"Upper respiratory tract toxicity of inhaled methylvinyl ketone in F344 rats and B6C3F1 mice","volume":"58","author":"Morgan","year":"2000","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib131","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0960-9822(95)00028-5","article-title":"The Ferrari of endocytosis?","volume":"5","author":"Morris","year":"1995","journal-title":"Curr Biol"},{"key":"10.1016\/j.neuro.2008.04.016_bib132","doi-asserted-by":"crossref","first-page":"9304","DOI":"10.1523\/JNEUROSCI.0519-06.2006","article-title":"\u03b1-Synuclein overexpression increases cytosolic catecholamine concentration","volume":"26","author":"Mosharov","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib133","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib134","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nature05289","article-title":"A network dysfunction perspective on neurodegenerative diseases","volume":"443","author":"Palop","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2008.04.016_bib135","doi-asserted-by":"crossref","first-page":"9572","DOI":"10.1073\/pnas.1133381100","article-title":"Neuronal depletion of calcium dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits","volume":"100","author":"Palop","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib136","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1523\/JNEUROSCI.22-11-04399.2002","article-title":"Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons","volume":"22","author":"Park","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib137","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/taap.1993.1170","article-title":"Acrolein-induced injury to cultured pulmonary artery endothelial cells","volume":"122","author":"Patel","year":"1993","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neuro.2008.04.016_bib138","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1021\/ja00984a014","article-title":"Application of the principle of hard and soft acids and bases to organic chemistry","volume":"89","author":"Pearson","year":"1967","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.neuro.2008.04.016_bib139","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ana.410440518","article-title":"Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients","volume":"44","author":"Pedersen","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib140","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1471-4159.2004.02423.x","article-title":"Could a loss of \u03b1-synuclein function put dopaminergic neurons at risk?","volume":"89","author":"Perez","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib141","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.freeradbiomed.2004.12.021","article-title":"Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice\u2014a model of familial amyotrophic lateral sclerosis","volume":"38","author":"Perluigi","year":"2005","journal-title":"Free Rad Bio Med"},{"key":"10.1016\/j.neuro.2008.04.016_bib142","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1046\/j.1471-4159.1999.721617.x","article-title":"4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites","volume":"72","author":"Picklo","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib143","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/taap.2002.9506","article-title":"Carbonyl toxicology and Alzheimer's disease","volume":"184","author":"Picklo","year":"2002","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neuro.2008.04.016_bib144","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0197-0186(01)00012-2","article-title":"Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease","volume":"39","author":"Pocernich","year":"2001","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuro.2008.04.016_bib145","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1074\/jbc.M608126200","article-title":"Effect of 4-hydroxy-2-nonenal modification on \u03b1-synuclein aggregation","volume":"282","author":"Qin","year":"2007","journal-title":"JBC"},{"key":"10.1016\/j.neuro.2008.04.016_bib146","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0306-4522(00)00293-1","article-title":"Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine","volume":"101","author":"Rabinovic","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2008.04.016_bib147","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.1068613","article-title":"Axonal self-destruction and neurodegeneration","volume":"296","author":"Raff","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuro.2008.04.016_bib148","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.taap.2006.06.001","article-title":"4-Hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione S-transferase A4-4 and cytochrome P450 2E1 in PC12 cells","volume":"216","author":"Raza","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neuro.2008.04.016_bib149","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.23-26-08989.2003","article-title":"PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation","volume":"23","author":"Richards","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib150","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1523\/JNEUROSCI.3034-05.2005","article-title":"Soluble \u03b2-amyloid1\u201340 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses","volume":"25","author":"Roselli","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib151","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"Rowland","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuro.2008.04.016_bib152","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0969-9961(02)00015-3","article-title":"No alterations of hippocampal neuronal number and synaptic bouton number in transgenic mouse model expressing the \u03b2-cleaved C-terminal APP fragment","volume":"12","author":"Rutten","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2008.04.016_bib153","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00293397","article-title":"Synapse loss in anterior horn neurons in amyotrophic lateral sclerosis","volume":"88","author":"Sasaki","year":"1994","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.neuro.2008.04.016_bib154","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(96)12314-4","article-title":"Ultrastructural change of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis","volume":"204","author":"Sasaki","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2008.04.016_bib155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(99)00374-2","article-title":"Ultrastructural change of synapses of Betz cells in patients with amyotrophic lateral sclerosis","volume":"268","author":"Sasaki","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2008.04.016_bib156","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1046\/j.1471-4159.1997.68052092.x","article-title":"4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease","volume":"68","author":"Sayre","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib157","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF00909348","article-title":"Reaction of protein SH-groups with 4-hydroxynonenal","volume":"102","author":"Schauenstein","year":"1971","journal-title":"Monatsh Chem"},{"key":"10.1016\/j.neuro.2008.04.016_bib158","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","article-title":"Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment","volume":"27","author":"Scheff","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2008.04.016_bib159","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.neurobiolaging.2003.08.002","article-title":"Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies","volume":"24","author":"Scheff","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2008.04.016_bib160","first-page":"213","article-title":"Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease","volume":"7","author":"Scheff","year":"1996","journal-title":"Dimentia"},{"key":"10.1016\/j.neuro.2008.04.016_bib161","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0197-4580(90)90059-9","article-title":"Quantitative assessment of cortical synaptic density in Alzheimer's disease","volume":"11","author":"Scheff","year":"1990","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2008.04.016_bib162","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuro.2008.04.016_bib163","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0891-5849(98)00021-5","article-title":"(E)-4-Hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease","volume":"25","author":"Selley","year":"1998","journal-title":"Free Rad Biol Med"},{"key":"10.1016\/j.neuro.2008.04.016_bib164","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.arr.2004.05.002","article-title":"Reactive oxygen species and synaptic plasticity in the aging hippocampus","volume":"3","author":"Serrano","year":"2004","journal-title":"Aging Res Rev"},{"key":"10.1016\/j.neuro.2008.04.016_bib165","doi-asserted-by":"crossref","first-page":"47270","DOI":"10.1074\/jbc.M207463200","article-title":"Conserved residues in the putative catalytic triad of human bile acid coenzyme A:amino acid N-acetyl transferase","volume":"277","author":"Sfakianos","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2008.04.016_bib166","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1523\/JNEUROSCI.4970-06.2007","article-title":"Natural oligomers of the Alzheimer amyloid-\u03b2 protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependant signaling pathway","volume":"27","author":"Shankar","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib167","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ana.410380424","article-title":"Oxidative damages to protein in sporadic motor neuron disease spinal cord","volume":"38","author":"Shaw","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib168","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","article-title":"Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden","volume":"62","author":"Simpson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2008.04.016_bib169","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/35086072","article-title":"Alzheimer's disease and A\u03b2 toxicity: from top to bottom","volume":"2","author":"Small","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib170","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.bbamem.2007.02.002","article-title":"The redox chemistry of the Alzheimer's disease amyloid \u03b2 peptide","volume":"1768","author":"Smith","year":"2007","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.neuro.2008.04.016_bib171","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1046\/j.1471-4159.1998.70052212.x","article-title":"Amyloid-\u03b2 deposition in Alzheimer transgenic mice is associated with oxidative stress","volume":"70","author":"Smith","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib172","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ana.410440419","article-title":"Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis","volume":"44","author":"Smith","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib173","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-\u03b2","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib174","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S0317167100019739","article-title":"A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposure","volume":"1","author":"Spencer","year":"1974","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib175","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/S0317167100119201","article-title":"A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms","volume":"1","author":"Spencer","year":"1974","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib176","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0896-6273(00)80310-4","article-title":"(S)NO signals: translocation, regulation and a consensus motif","volume":"18","author":"Stamler","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2008.04.016_bib177","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0092-8674(01)00495-0","article-title":"Nitrosylation: the prototypic redox-based signaling mechanism","volume":"106","author":"Stamler","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.neuro.2008.04.016_bib178","first-page":"1051","article-title":"Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress","volume":"156","author":"Stamer","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2008.04.016_bib179","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1523\/JNEUROSCI.0462-04.2004","article-title":"Cortical synaptic integration in vivo is disrupted by amyloid-\u03b2 plaques","volume":"24","author":"Stern","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib180","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neuro.2008.04.016_bib181","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1471-4159.1997.69031161.x","article-title":"The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins","volume":"69","author":"Subramaniam","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib182","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2006.01.021","article-title":"The various aggregation states of \u03b2-amyloid 1\u201342 mediate different effects on oxidative stress, neurodegeneration, and BACE-1 expression","volume":"41","author":"Tamagno","year":"2006","journal-title":"Free Rad Biol Med"},{"key":"10.1016\/j.neuro.2008.04.016_bib183","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuint.2006.05.004","article-title":"Selective loss of synaptic proteins in Alzheimer's disease evidence for an increased severity with APOE \u025b4","volume":"49","author":"Tannenberg","year":"2006","journal-title":"Neurochem Intelrnatl"},{"key":"10.1016\/j.neuro.2008.04.016_bib184","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0896-6273(04)00533-1","article-title":"Clearance of Alzheimer's A\u03b2 peptide: the many roads to perdition","volume":"43","author":"Tanzi","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2008.04.016_bib185","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ana.410300410","article-title":"Physical basis of cognitive alterations in Alzheimer's disease: synapse loss in major correlate of cognitive impairment","volume":"30","author":"Terry","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuro.2008.04.016_bib186","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00005072-196310000-00005","article-title":"The structure of neurofibrillary tangles in Alzheimer's disease","volume":"22","author":"Terry","year":"1963","journal-title":"J Neuropathol"},{"key":"10.1016\/j.neuro.2008.04.016_bib187","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1073\/pnas.89.10.4544","article-title":"Modification of histidine residues in proteins by reaction with 4-hydroxynonenal","volume":"89","author":"Uchida","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib188","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1016\/S0021-9258(18)53264-6","article-title":"Covalent attachment of 4-hydroxynonenal to glyceraldehydes-3-phosphate dehydrogenase","volume":"268","author":"Uchida","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2008.04.016_bib189","first-page":"109","article-title":"Current status of acrolein as a lipid peroxidation product","volume":"9","author":"Uchida","year":"1999","journal-title":"TCM"},{"key":"10.1016\/j.neuro.2008.04.016_bib190","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0163-7827(03)00014-6","article-title":"4-Hydroxy-2-nonenal: a product and mediator of oxidative stress","volume":"42","author":"Uchida","year":"2003","journal-title":"J Prog Lipid Res"},{"key":"10.1016\/j.neuro.2008.04.016_bib191","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1006\/brcg.2001.1500","article-title":"Neuronal changing in normal human aging and Alzheimer's disease","volume":"49","author":"Ulyings","year":"2002","journal-title":"Brain Cogn"},{"key":"10.1016\/j.neuro.2008.04.016_bib192","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0009-2797(97)00096-3","article-title":"Interactions of \u03b1,\u03b2-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1","volume":"108","author":"Van Iersel","year":"1997","journal-title":"Chem Biol Int"},{"key":"10.1016\/j.neuro.2008.04.016_bib193","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1523\/JNEUROSCI.3478-07.2007","article-title":"\u03b2-Amyloid modulation of synaptic transmission and plasticity","volume":"27","author":"Venkiraramani","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib194","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00401-004-0977-1","article-title":"Sublethal dose of 4-hydroxynonenal reduces intracellular calcium in surviving motor neurons in vivo","volume":"109","author":"Vigh","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neuro.2008.04.016_bib195","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.neuint.2005.12.003","article-title":"Increased brain levels of 4-hydroxy-2-nanonal glutathione conjugates in severe Alzheimer's disease","volume":"48","author":"Volkel","year":"2006","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuro.2008.04.016_bib196","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A\u03b2 oligomers\u2014a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuro.2008.04.016_bib197","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer's disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2008.04.016_bib198","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid \u03b2 protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2008.04.016_bib199","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3940(93)90103-R","article-title":"Coupling of muscarinic receptors to GTP proteins in postmortem human brain\u2014alterations in Alzheimer's disease","volume":"150","author":"Warpman","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuro.2008.04.016_bib200","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00702-003-0012-z","article-title":"Synaptic vesicle transport and synaptic membrane transporter sites in excitatory amino acid nerve terminals in Alzheimer's disease","volume":"110","author":"Westphalen","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuro.2008.04.016_bib201","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.neurobiolaging.2005.06.004","article-title":"Increased levels of 4-hydroxynonenal and acrolein, neurotic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease","volume":"27","author":"Williams","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuro.2008.04.016_bib202","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0891-5849(89)90137-8","article-title":"Biological interactions of \u03b1,\u03b2-unsaturated aldehydes","volume":"7","author":"Witz","year":"1989","journal-title":"Free Rad Biol Med"},{"key":"10.1016\/j.neuro.2008.04.016_bib203","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tins.2003.10.012","article-title":"Synaptic frailty and clathrin-mediated synaptic vesicle trafficking in Alzheimer's disease","volume":"27","author":"Yao","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuro.2008.04.016_bib204","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0969-9961(02)00009-8","article-title":"Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease","volume":"12","author":"Yao","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2008.04.016_bib205","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1073\/pnas.93.7.2696","article-title":"Immunohistochmical detection of 4-hydroxynonenal protein adducts in Parkinson disease","volume":"93","author":"Yoritaka","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuro.2008.04.016_bib206","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0098-2997(03)00024-4","article-title":"4-Hdroxynonenal and neurodegenerative diseases","volume":"24","author":"Zarkovic","year":"2003","journal-title":"Mol Asp Med"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X08000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X08000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T20:17:42Z","timestamp":1631218662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X08000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":206,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0161813X08000624"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2008.04.016","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}